April 23, 2021

Prestige Scientific Announces Successfully Completed Search for a Director of Program and Alliance Management

News

Philadelphia, PA. – Prestige Scientific is excited to announce the successful completion of a search for a Director of Program and Alliance Management for our clinical-stage biotechnology client focused on developing therapies for the treatment of rare genetic diseases.

The Director of Program and Alliance Management will play an important role in supporting our client's development programs and portfolio.  This individual will be responsible for leading one or more development programs and development teams, developing and implementing robust integrated program plans and program strategies, tracking progress against key milestones and program goals, and ensuring effective communication across all internal stakeholders. This individual will also be responsible for working with senior leadership and program teams to plan and execute on collaboration programs and maintain oversight of partner relationships.

Our client’s mission is to advance their proprietary gene editing and gene therapy platform and potentially cure rare genetic diseases.

Prestige Scientific presented the candidate that would ultimately be hired within 8 days of starting the project. The project was completed in 46 days. Congratulations to Jake Kind for leading this search! Jake has completed two Director of Program and Alliance Management searches in 2021 so far. Get in touch with Jake, jkind@prestigescientific.com, or find him on LinkedIn.

About Prestige Scientific:

Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.